BioMarin Pharmaceutical Inc. (LON:0HNC)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,273	10,006	14,259	15,963	11,979	11,659
Market Cap Growth	-20.00%	-29.83%	-10.67%	33.26%	2.74%	1.68%
Enterprise Value	7,775	9,744	14,235	15,811	11,985	11,659
Last Close Price	43.33	52.46	75.71	83.80	66.15	64.78
PE Ratio	20.40	29.35	108.34	135.87	-	18.64
PS Ratio	3.62	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.84	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	2.00	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	17.12	25.70	290.28	350.06	77.63	-
P/OCF Ratio	15.26	21.87	114.04	109.34	53.26	186.47
EV/Sales Ratio	3.55	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	12.76	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	14.63	21.40	97.60	348.42	-	-
EV/FCF Ratio	16.09	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.73	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.96	1.30	18.12	20.38	5.38	-
Asset Turnover	0.42	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.46	0.50	0.53	0.60	1.49	1.67
Quick Ratio	3.20	2.96	1.45	2.98	2.54	3.07
Current Ratio	5.52	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.64%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.38%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Capital (ROIC)	7.12%	5.76%	1.97%	0.61%	-0.87%	-1.24%
Return on Capital Employed (ROCE)	11.00%	8.90%	3.30%	0.90%	-	-
Earnings Yield	4.90%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	5.84%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-1.65%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.